Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mixed results for a malaria vaccine.

Literature DB >> 22146460

Mixed results for a malaria vaccine.

Victor Nussenzweig¹, Michael F Good, Adrian V S Hill.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 22146460 DOI： 10.1038/nm1211-1560

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

10 in total

1. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Authors: Selidji Todagbe Agnandji; Bertrand Lell; Solange Solmeheim Soulanoudjingar; José Francisco Fernandes; Béatrice Peggy Abossolo; Cornelia Conzelmann; Barbara Gaelle Nfono Ondo Methogo; Yannick Doucka; Arnaud Flamen; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Arlindo Nhamuave; Diana Quelhas; Quique Bassat; Sofia Mandjate; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Omar Juma; Mwanajaa Shomari; Kafuruki Shubis; Francisca Machera; Ali Said Hamad; Rose Minja; Ali Mtoro; Alma Sykes; Saumu Ahmed; Alwisa Martin Urassa; Ali Mohammed Ali; Grace Mwangoka; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Marc Christian Tahita; William Kaboré; Sayouba Ouédraogo; Yara Sandrine; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Chris Odero; Martina Oneko; Kephas Otieno; Norbert Awino; Jackton Omoto; John Williamson; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Otsyula Nekoye; Stacey Gondi; Allan Otieno; Bernhards Ogutu; Ruth Wasuna; Victorine Owira; David Jones; Agnes Akoth Onyango; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Jesse Gitaka; Charity Maingi; Trudie Lang; Ally Olotu; Benjamin Tsofa; Philip Bejon; Norbert Peshu; Kevin Marsh; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; Samuel Ayamba; Kingsley Kayan; Ruth Owusu-Ofori; David Dosoo; Isaac Asante; George Adjei; George Adjei; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Hassan Kilavo; Coline Mahende; Edwin Liheluka; Martha Lemnge; Thor Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Alex Agyekum; Larko Owusu; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Ruthendo Nkomo; Albans Msika; Allan Jumbe; Nelecy Chome; Dalitso Nyakuipa; Joseph Chintedza; W Ripley Ballou; Myriam Bruls; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Johan Vekemans; Terrell Carter; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal: N Engl J Med Date: 2011-10-18 Impact factor: 91.245

2. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Authors: K A Bojang; P J Milligan; M Pinder; L Vigneron; A Alloueche; K E Kester; W R Ballou; D J Conway; W H Reece; P Gothard; L Yamuah; M Delchambre; G Voss; B M Greenwood; A Hill; K P McAdam; N Tornieporth; J D Cohen; T Doherty
Journal: Lancet Date: 2001-12-08 Impact factor: 79.321

3. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.

Authors: Pedro L Alonso; Jahit Sacarlal; John J Aponte; Amanda Leach; Eusebio Macete; Pedro Aide; Betuel Sigauque; Jessica Milman; Inacio Mandomando; Quique Bassat; Caterina Guinovart; Mateu Espasa; Sabine Corachan; Marc Lievens; Margarita M Navia; Marie-Claude Dubois; Clara Menendez; Filip Dubovsky; Joe Cohen; Ricardo Thompson; W Ripley Ballou
Journal: Lancet Date: 2005-12-10 Impact factor: 79.321

4. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.

Authors: V Ann Stewart; Shannon M McGrath; Patrice M Dubois; Maria G Pau; Pascal Mettens; Joseph Shott; Michelle Cobb; J Robert Burge; David Larson; Lisa A Ware; Marie-Ange Demoitie; Gerrit Jan Weverling; Babak Bayat; Jerome H H V Custers; Marie-Claude Dubois; Joe Cohen; Jaap Goudsmit; D Gray Heppner
Journal: Infect Immun Date: 2007-02-16 Impact factor: 3.441

5. Our impasse in developing a malaria vaccine.

Authors: Michael F Good
Journal: Cell Mol Life Sci Date: 2011-02-15 Impact factor: 9.261

6. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.

Authors: Kwaku Poku Asante; Salim Abdulla; Selidji Agnandji; John Lyimo; Johan Vekemans; Solange Soulanoudjingar; Ruth Owusu; Mwanajaa Shomari; Amanda Leach; Erik Jongert; Nahya Salim; Jose F Fernandes; David Dosoo; Maria Chikawe; Saadou Issifou; Kingsley Osei-Kwakye; Marc Lievens; Maria Paricek; Tina Möller; Stephen Apanga; Grace Mwangoka; Marie-Claude Dubois; Tigani Madi; Evans Kwara; Rose Minja; Aurore B Hounkpatin; Owusu Boahen; Kingsley Kayan; George Adjei; Daniel Chandramohan; Terrell Carter; Preeti Vansadia; Marla Sillman; Barbara Savarese; Christian Loucq; Didier Lapierre; Brian Greenwood; Joe Cohen; Peter Kremsner; Seth Owusu-Agyei; Marcel Tanner; Bertrand Lell
Journal: Lancet Infect Dis Date: 2011-07-22 Impact factor: 25.071

7. Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation.

Authors: Vasee Moorthy; Zarifah Reed; Peter G Smith
Journal: Vaccine Date: 2007-02-02 Impact factor: 3.641

8. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

Authors: Philip Bejon; John Lusingu; Ally Olotu; Amanda Leach; Marc Lievens; Johan Vekemans; Salum Mshamu; Trudie Lang; Jayne Gould; Marie-Claude Dubois; Marie-Ange Demoitié; Jean-Francois Stallaert; Preeti Vansadia; Terrell Carter; Patricia Njuguna; Ken O Awuondo; Anangisye Malabeja; Omar Abdul; Samwel Gesase; Neema Mturi; Chris J Drakeley; Barbara Savarese; Tonya Villafana; W Ripley Ballou; Joe Cohen; Eleanor M Riley; Martha M Lemnge; Kevin Marsh; Lorenz von Seidlein
Journal: N Engl J Med Date: 2008-12-08 Impact factor: 91.245

Review 9. From the circumsporozoite protein to the RTS, S/AS candidate vaccine.

Authors: Joe Cohen; Victor Nussenzweig; Ruth Nussenzweig; Johan Vekemans; Amanda Leach
Journal: Hum Vaccin Date: 2010-01-30

10. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum.

Authors: Alyssa E Barry; Lee Schultz; Caroline O Buckee; John C Reeder
Journal: PLoS One Date: 2009-12-30 Impact factor: 3.240

10 in total

2 in total

Review 1. Looking under the skin: the first steps in malarial infection and immunity.

Authors: Robert Ménard; Joana Tavares; Ian Cockburn; Miles Markus; Fidel Zavala; Rogerio Amino
Journal: Nat Rev Microbiol Date: 2013-10 Impact factor: 60.633

2. Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose.

Authors: Alexander M Jacobine; Jennifer R Mazzone; Rachel D Slack; Abhai K Tripathi; David J Sullivan; Gary H Posner
Journal: J Med Chem Date: 2012-08-27 Impact factor: 7.446

2 in total